NordicNeuroLab Chooses eMagin OLED Microdisplays for fMRI Application

BELLEVUE, Wash., Feb. 15, 2006 - eMagin Corporation (AMEX:EMA), a leader in personal display systems and technologies, is supplying SVGA 3D OLED microdisplays for NordicNeuroLab’s new VisualSystem. The VisualSystem product provides true 3D visual stimuli for fMRI (functional magnetic resonance imaging) applications.

fMRI, based on the discovery that magnetic resonance imaging can be used to map changes in brain fluid flow and chemical changes that correspond to human brain function, is becoming the diagnostic method of choice for learning how a normal, diseased, or injured brain is working, as well as for assessing the potential risks of surgery. Future applications include the mapping of pain areas in the brain. According to an analysis by Alta Biomedical Group LLC for the Washington Technology Center, over 18 million MRI procedures are performed annually in the US.

According to Dr. Tormod Thomsen, Managing Director, NordicNeuroLabs, “Studies show that visual stimulation for fMRI measurements are more reliable with direct input through video goggles than with the conventional use of projection screens. eMagin’s OLED microdisplays provide the contrast, color, and 3D capability to deliver the convincing visual stimuli required.”

Designed with both the patient and operator in mind, NordicNeuroLab’s new VisualSystem can be mounted easily on top of most modern head coils. Its adjustable arm allows fast positioning of the microdisplays into the preferred angle of view, and differences in pupil distance and dioptric correction are also easily adjustable. The VisualSystem features a unique optical setup to enlarge images generated by small, precision image OLED displays, and projects images to the patient’s eyes without use of fiber cables and risk of dead or grey pixels.

“Readily accessible 3D imagery has proven to be highly useful for several fast growing medical applications,” noted Susan Jones, chief marketing and strategy officer, eMagin Corporation. “What NordicNeuroLabs has accomplished with their VisualSystem demonstrates the kind of creativity that’s making medical instruments more accurate, effective and flexible.”

About NordicNeuroLab: With over 10 years of fMRI-experience, NordicNeuroLab manufactures and supplies high-quality products for functional imaging. Its product line features a seamlessly integrated set of software and hardware components that can also be used separately to simplify the complex operations required by functional magnetic resonance imaging. All of NordicNeuroLab’s products have been designed and developed in close cooperation with both research and clinical groups. The company provides exceptional customer support, using customer feedback to continue to develop optimal products. NordicNeuroLab has also custom developed novel solutions, ranging from customer-specified technical solutions to development and programming of fMRI-experiments. For further information, please visit www.nordicneurolab.com

About eMagin Corporation: A leader in OLED technology and personal display systems, eMagin manufactures and integrates high-resolution OLED microdisplays, magnifying optics, and systems technologies to create a virtual image comparable to that of a large computer monitor or a large-screen television. eMagin’s OLED displays have been incorporated into a variety of near-eye imaging products for military, industrial, medical, and consumer markets that choose eMagin’s award-winning technology as a core component for their solutions. eMagin’s first personal display system, the Z800 3DVisor, provides superb 3D stereovision and headtracking for PC gaming, training and simulation, and other applications. It won the CEA’s Best of Innovations award in the digital display category and won additional recognition in the electronic gaming category. eMagin’s microdisplay manufacturing and R&D operations are co-located with IBM on its campus in East Fishkill, New York. System design facilities and sales and marketing are located in Bellevue, Washington. A sales office is located in Tokyo, Japan. For additional information, please visit www.emagin.com and www.3dvisor.com.
Forward Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including those regarding eMagin Corporation and its subsidiaries’ expectations, intentions, strategies and beliefs pertaining to future events or future financial performance. All statements contained herein are based upon information available to eMagin’s management as of the date hereof, and actual results may vary based upon future events, both within and without eMagin management’s control. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” the negative of such terms, or other comparable terminology. These statements are only predictions. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors, including those described in the Company’s most recent filings with the SEC. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. The business and operations of the Company are subject to substantial risks which increase the uncertainty inherent in forward-looking statements. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.

Note:eMagin, Eyebud, 3DVisor, X800 and Z800 are trademarks of eMagin Corporation.

Contact Information

Joe Runde

Media Contact

eMagin Corporation

Contact via E-mail